Escherichia coli strains cultured from 74 patients with inflammatory bowel disease at different stages of disease activity (Crohn's disease (40), ulcerative colitis (34)) and 18 healthy controls were studied in relation to haemolysin and verotoxin production and enteroadherence. Disease activity was assessed by standard clinical and laboratory tests. Haemolytic E coli were isolated from 18% of patients with Crohn's disease, 24% with ulcerative colitis, and 11% of healthy controls. None of these differences was significant. No verotoxin producing strains were detected among the 216 E coli isolates examined but the extract from five strains (Crohn's (4), ulcerative colitis (1) produced a distinctive cytopathic effort on Vero celi monolayers which was later shown not to be due to verotoxin. The adhesion indices of E coli isolates cultured were: mean (SEM) 42*2 (6.4) for Crohn's disease, 43*3 (6.2) for ulcerative colitis, and 11.3 (2.0) for normal controls (p..00001). Adhesive E coli were isolated from 62% of patients with Crohn's disease and 68% with ulcerative colitis but from only 6% of normal controls (p<0.0002). Neither haemolysin production nor enteroadherence was dependent upon disease activity, disease location, sulphasalazine treatment, or previous intestinal resection. These results indicate that only enteroadherent E coli were frequently associated with inflammatory bowel disease; their relation to the pathogenesis of these conditions, however, remains uncertain.
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Escherichia coli strains are the predominant aerobic or facultative Gram negative rods in the normal human colon, where they play an important role in promoting the stability of the intestinal microbial flora and in maintaining the normal intestinal physiology.' Epidemiological and volunteer studies have confirmed that certain E coli strains can be true intestinal pathogens in animals and in man. 23 These strains are associated with well defined diarrhoeal syndromes. Diarrhoeagenic E coli belong to a small number of serotypes which differ from those normally resident in the colon in possessing distinct virulence properties of which the production of enterotoxins (enterotoxigenic E coli), tissue invasion (enteroinvasive E coli), and adherence to enterocytes (enteroadherent E coli) have been studied most widely.' In many pathogenic strains, however, the virulence mechanism remains to be defined. We HAEMOLYSIN ASSAY Haemolysin production was tested using blood agar containing sheep erythrocytes prepared as previously described. 14 Coded E coli isolates were inoculated on the blood agar and incubated aerobically at 37°C for [18] [19] [20] [21] [22] [23] [24] hours. The presence of haemolysis could be seen as a clear zone surrounding the inoculum.
VEROTOXIN ASSAY
The method of extraction of verotoxin from verotoxin producing E coli using Polymyxin B (Sigma, Poole) has been described by Karmali et al'5 16 and is based on fact that Polymyxin B releases the usually high concentration of verotoxin present in the periplasmic space'7 and that Polymyxin B releases 80-90% of the cytopathic activity of Shigella dysenteriae type 1 cells.'8 Briefly, the E coli isolates were grown aerobically on nutrient agar plates for 18 hours. (4) , ulcerative colitis (1) produced a distinctive cytopathic effect on Vero cells on repeated testing (Fig iB) . This effect was reproducible and detectable at both dilutions of extract. Further testing showed that although this cytopathic effect was similar to that produced by verotoxin (Fig 1C) , verotoxin production by these strains could not be confirmed.
ADHESIVENESS
The adhesion indices for E coli isolates from patients with Crohn's disease, ulcerative colitis, and normal controls are shown in Figure 2 . The mean (SEM) adhesion index of E coli isolates from patients with Crohn's disease (42-2 (6-4)) was not different from those with ulcerative colitis (43.4 (6.2)), both were significantly higher than the index from healthy controls (11 3 (2 0)) (p<0 0001 in both cases). Adhesive E coli were isolated from 71% ofpatients with active Crohn's disease, 53% with quiescent disease, 67% with active colitis, and 68% with quiescent colitis (no significant difference) but from only 6% of normal controls. The differences between each disease group and normal controls were significant (pO0O0002). The occurrence of E coli with adhesive properties was independent of disease activity, disease site, previous surgery, or concomitant sulphasalazine therapy (data not shown).
Discussion
The possible importance of qualitative rather than quantitative changes in the E coli flora in patients with inflammatory bowel disease has been emphasised by the observation that enteroadherent strains are more common in these patients than in control subjects.' "' We have 
confirmed this and further extended the previous studies by a more detailed examination of all patient and disease factors that may influence the isolation of adhesive E coli, and also by studying other virulence factors of E coli that have not been examined hitherto.
Enteroadherence is a feature of many enteric pathogens such as Vibrio cholerae. This characteristic enables these strains to resist mechanical removal from the intestine. In this study a significant proportion of patients with inflammatory bowel disease harboured E coli with adhesive properties in their stool. Sixty two per cent of patients with Crohn's disease and 68% with ulcerative colitis had these strains compared with only 6% of normal controls. Adhesive E coli were as frequently isolated during the acute exacerbations of both Crohn's disease and ulcerative colitis as when the disease was quiescent. Furthermore, other factors such as age, sex, sulphasalazine therapy, anatomical site of the disease, or previous intestinal resection had no influence on the isolation rate of these strains. Nine patients with newly diagnosed, and therefore previously untreated, ulcerative colitis harboured adhesive strains as frequently as patients with long standing disease.
The factors favouring the acquisition of enteroadherent E coli are not certain. This property is plasmid mediated and may therefore be gained or lost.2' The lack of correlation with disease activity indicates that other conditions in the intestine may enable the adhesive strains to predominate over the normal E coli. However, the possibility that some of the acute relapses in inflammatory bowel disease might be initiated by enteropathogenic E coli remains tenable.
The role of verotoxin producing E coli infection in inflammatory bowel disease has not previously been reported. Hunt et a122 described three patients with presumed ulcerative colitis from whom a verotoxin producing E coli strain (0157:H7) was isolated. However, in only one of their cases was a final diagnosis of ulcerative colitis confirmed. In the present study, none of 246 E coli isolates, including 216 isolates from 74 patients with inflammatory bowel disease, produced verotoxin. All of those with clinically active disease had bloody diarrhoea. Because the proportion of verotoxin producing E coli in the faecal E coli population may be as low as 5-20%, it has been suggested that a large number of colonies from the primary medium should be examined.'56 Since only a limited number of E coli serotypes are usually cultured from the faeces of patients with inflammatory bowel disease,'0 the testing of three or four E coli isolates from each patient for verotoxin production gives an overall estimate of the prevalence of these strains in such conditions. Therefore, our findings indicate that verotoxin producing E coli infection plays little if any role in the pathogenesis of inflammatory bowel disease.
The extracts of five E ccli strains produced a distinctive cytopathic effect on Vero cell similar to that produced by verotoxin. All but one were isolated from patients with Crohn's disease. It is exceedingly unlikely that alterations in the media used -for example pH or temperature -were responsible, because these toxic effects were reproducible and evident when the E coli strains were tested simultaneously with other positive and negative control strains. A more likely hypothesis is that these cytopathic effects resulted from an as yet unidentified toxin.
Haemolysin production is frequently associated with E coli strains causing urinary tract infection,'3 peritonitis, and appendicitis.24 Therefore, haemolysis is a feature of pathogenic E coli. The incidence of haemolytic E coli in inflammatory bowel disease has been studied only in relation to ulcerative colitis.7'4 Similar studies in Crohn's disease have not been reported. In this study, haemolytic E coli strains were isolated from a small proportion of patients with inflammatory bowel disease (18% of patients with Crohn's disease and 24% of those with ulcerative colitis). These figures were not significantly different from normal controls (11%) or from patients with urinary tract infection (37%). Our results are in agreement with those reported by Cooke,'4 who found haemolytic E coli in 20% of 50 patients with ulcerative colitis. Our data indicate that in both Crohn's disease and ulcerative colitis, the isolation of haemolytic strains does not differ according to disease activity, for these strains were equally distributed in active and quiescent disease. No patient or disease factors affected the prevalence of these strains. This finding contrasts with an earlier report7 which indicated that in ulcerative colitis haemolytic E coli were isolated more frequently from patients with active than quiescent disease. The smaller number of patients included in our study may be the reason for this discrepancy.
The significance of the isolation of haemolytic E coli in patients with inflammatory bowel disease is not certain. Follow up over a six month period for haemolysin and necrotoxin producing E coli isolated from patients with ulcerative colitis has shown that the acquisition of these strains tended to follow rather than precede the acute relapse.7
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